Literature DB >> 26721808

Challenging Argatroban Management of a Child on Extracorporeal Support and Subsequent Heart Transplant.

Gregory J Latham1, Christa Jefferis Kirk2, Amy Falconer2, Renee Dickey2, Erin L Albers3, David Michael McMullan3.   

Abstract

A 6-year-old child developed heparin-induced thrombocytopenia while on extracorporeal life support. Hours after a difficult transition from heparin to argatroban for anticoagulation therapy, the child underwent heart transplantation. Intraoperative management was plagued with circuit thrombus formation while on cardiopulmonary bypass and subsequent massive hemorrhage after bypass. We review the child's anticoagulation management, clinical challenges encountered, and review current literature related to the use of argatroban in pediatric cardiac surgery.
© The Author(s) 2015.

Entities:  

Keywords:  HIT; anticoagulants; bivalirudin; cardiopulmonary bypass; children; coagulation; coagulopathy; congenital heart disease; hemorrhage; thrombosis

Mesh:

Substances:

Year:  2015        PMID: 26721808     DOI: 10.1177/1089253215624766

Source DB:  PubMed          Journal:  Semin Cardiothorac Vasc Anesth        ISSN: 1089-2532


  3 in total

1.  Perioperative care in an adolescent patient with heparin-induced thrombocytopenia for placement of a cardiac assist device and heart transplantation: case report and literature review.

Authors:  Mineto Kamata; Roby Sebastian; Patrick I McConnell; Daniel Gomez; Aymen Naguib; Joseph D Tobias
Journal:  Int Med Case Rep J       Date:  2017-02-14

Review 2.  Coagulation and Bleeding Management in Pediatric Extracorporeal Membrane Oxygenation: Clinical Scenarios and Review.

Authors:  Lisa A Hensch; Shiu-Ki Rocky Hui; Jun Teruya
Journal:  Front Med (Lausanne)       Date:  2019-01-11

3.  Use of argatroban in combination with nafamostat mesilate in open-heart surgery for a pediatric patient with heparin-induced thrombocytopenia type II: a case report.

Authors:  Shuji Kawamoto; Eriko Kusudo; Kazuhiko Fukuda
Journal:  JA Clin Rep       Date:  2020-01-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.